Startups & Business News

Surgerii Robotics Secures $100M Series D Funding Round

futureTEKnow
January 1, 2026

Surgerii Robotics just landed a massive $100M Series D funding round. This cash boost sets them up to push their SHURUI single-port surgical robot worldwide.

Surgerii Robotics Series D Funding Breakdown

Surgerii Robotics, based in Beijing, snagged $100 million in Series D funding late last year. Led by big names like Grishin Robotics, the round values the company at over $1 billion. This marks their biggest raise yet, building on past rounds that fueled SHURUI single-port surgical robot development.

The money comes at a perfect time. With surgical robotics global expansion heating up, Surgerii aims to scale production and hit new markets fast. No word on exact founders in public posts, but the team’s deep roots in continuum robotics shine through their patented tech.

Why SHURUI Single-Port Surgical Robot Stands Out

The SHURUI single-port surgical robot squeezes three instruments and a 3D endoscope through one tiny 2.5 cm cut. Snake-like arms bend in wild ways, dodging collisions while giving surgeons full 360-degree access.

Picture this: no bulky multi-arm setups clashing outside the body. SHURUI’s dual continuum mechanism uses superelastic nitinol rods for heavy loads and smooth moves. It’s already cleared CE marks for urology, gynecology, general, thoracic surgery—even pediatric cases.

Doctors love how it cuts trauma. Procedures like prostatectomies or lung surgeries wrap up with less blood loss and quicker recovery. Early trials show console times around 117 minutes, with zero conversions to open surgery.

Fueling Surgical Robotics Global Expansion

This Surgerii Robotics Series D funding isn’t just for show—it’s rocket fuel for going global. Surgerii plans more clinical sites in Europe and beyond, partnering with places like IRCAD for training hubs.

China’s medtech scene is booming, and Surgerii leads the pack in minimally invasive single-port surgery. Their robot fills a gap: true single-port options for complex ops, where rivals like da Vinci still lean multi-port.

Expect factory ramps and regulatory pushes soon. With 800+ patents and 20 years of research, they’re not starting from scratch.

Minimally Invasive Single-Port Surgery Game Changer

Minimally invasive single-port surgery means smaller scars, less pain, faster bounces back. SHURUI nails this with flexible arms that twist like tentacles, perfect for tight spots in kids or chest ops.

Take thoracic cases: surgeons dock in 4 minutes, operate without extra ports. One study clocked 100% R0 resections—clean margins every time. For patients, that’s milder recovery over traditional laparoscopy.

Surgerii’s edge? Modular carts swap for single, multi, or hybrid ports. No full system redo per procedure.

What's Next for Surgerii

Surgerii eyes FDA nods and wider trials. Their surgeon console packs 3D vision, image guidance, and intuitive controls—built for real-world grind.

This Surgerii Robotics Series D funding win ripples out. More funding means faster tech tweaks, broader access. For patients, that spells safer, scar-free surgeries sooner.

futureTEKnow is a leading source for Technology, Startups, and Business News, spotlighting the most innovative companies and breakthrough trends in emerging tech sectors like Artificial Intelligence (AI), Robotics, and the Space Industry.

Become a contributor

Find out how

Discover the companies and startups shaping tomorrow — explore the future of technology today.